Akademik Veri Yönetim Sistemi
Journal of Clinical Nursing, 2025 (SCI-Expanded)
Background: Emergency nurses frequently encounter traumatic events and have difficulty coping with the stress they experience. The stress nurses experience increases the likelihood of secondary traumatic stress. It is important to address the concept of psychological resilience in order for emergency nurses to cope with the difficulties they encounter. The aim of this systematic review is to explore the effect of secondary traumatic stress on psychological resilience in emergency nurses. Methods: The systematic review was prepared according to the PRISMA guidelines. Studies evaluating the effects of secondary traumatic stress on psychological resilience in emergency nurses were eligible. The Cochrane risk of bias tool was used for quality assessment. The findings of this review are presented using a narrative synthesis. Data Sources: Web of Science, Scopus, CINAHL Complete, Science Direct, Ebsco, PubMED/MEDLINE, TR Index, Index Copernicus and Sobiad databases were searched between the October 2021 and January 2024 without language and year restriction. Results: This review included five studies involving 234 emergency nurses. Two of these studies were written with qualitative methods, two with quantitative methods, and one with mixed methods. The search was conducted without any year limitation. The studies included in the review were between 2013 and 2022. Discussion: Only five studies that met the inclusion criteria could be accessed. It was determined that the secondary traumatic stress level of emergency nurses was high and secondary traumatic stress decreased as psychological resilience increased. It is thought that this study will guide future studies planned to reduce secondary traumatic stress and increase psychological resilience of emergency nurses. Relevance to Clinical Practice: Detailed studies are needed to determine the relationship between secondary traumatic stress and psychological resilience in emergency nurses, to determine its impact on health care services and its impact on clinical practice. Reporting Method: PRISMA guidelines. Patient or Public Contribution: No Patient or Public Contribution. Trial Registration: ClinicalTrials.gov identifier: PROSPERO CRD42022322117.